Biotech exec Jeremy Levin on the industry’s strategic turning point - Top-Institutions - MDSpire

Biotech exec Jeremy Levin on the industry’s strategic turning point

  • By

  • Adam Feuerstein

  • Allison DeAngelis

  • Elaine Chen

  • May 28, 2026

  • 0 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Biotechnology

  • #2

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, Maryland

    Key Differentiators

    • Oncology
    • Neurology
    • Biotechnology

  • #3

    Mass General Brigham
    Mass General Brigham

    Boston, Massachusetts

    Key Differentiators

    • General Medicine
    • Biotechnology

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology
    • Biotechnology

  • #5

    Harvard Medical School
    Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Medical Education
    • Biotechnology

Original Source(s)

Biotech exec Jeremy Levin on the industry’s strategic turning point

  • by Adam Feuerstein, Allison DeAngelis, Elaine Chen

  • May 28, 2026

Related Content

Human-Relevant Discovery: iPSC Models and the Future of Rare Disease R&D

A Q&A with iXCells Biotechnologies CEO, Steve Smith

  • February 25, 2026

  • 9 min
Cancer risk and the burden of housing and energy insecurity: a scoping review

Future landscapes of women’s hormone-sensitive cancers: unraveling global trends, age stratification, and regional inequities (1990–2035)